2m 2m 2m 2m 2m 2m 2m
Annovis Bio (ANVS)
NYSE
$1.74-$0.02 (-1.25%)
Price as of Jul 14, 2026 8:42 AM EDT- $74.9MMarket Cap
- -38.46%1-Year Change
- BiotechnologyIndustry
Annovis Bio (ANVS)
$1.74-$0.02 (-1.25%)
ANVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.76 | ||
Change | -$0.10 (-5.38%) | ||
Open | $1.85 | ||
High | $1.85 | ||
Low | $1.72 | ||
Previous Close | $1.86 | ||
Volume | 969,196 | ||
30-Day Average Volume | 976,942 | ||
1-Week Change | -10.66% | ||
1-Month Change | -1.12% | ||
1-Year Change | -38.46% | ||
3-Year Change | -87.15% | ||
5-Year Change | -98.55% | ||
Fundamentals | |||
Shares Outstanding | 42.5M | ||
Total Assets | $16.2M | ||
Market Cap | $74.9M | ||
Enterprise Value | $60.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$9.0M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $1.4M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 24 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue